PFE

Q: What is the price of Pfizer (PFE) today?

The price of Pfizer (PFE) today is US$ 24,78, with a variation of -9.02% compared to the last year. The price of Pfizer (PFE) started the year trading around US$ 0,00 and today it is at US$ 24,78. Follow the real-time price chart, the historical price of Pfizer (PFE), and stock data from Ibovespa and international markets.

Q: When does Pfizer (PFE) pay dividends?

Pfizer (PFE) distributed dividends in the last year,in the months of March, June and September totaling US$ 1,29. The Dividend Yield for the last 12 months is 6,25%.

Q: Pfizer (PFE) is it worth it?

Currently, Pfizer (PFE) is priced at US$ 24,78, with a P/E of 16,92%, representing a deviation of -254,22% from its historical average P/E. In the last year, the stock showed a variation of -9.02% in its price and distributed US$ 1,29 in dividends, resulting in a Dividend Yield of 6,25%. The total shareholder return was -9,02%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Pfizer (PFE)?

Investing in stocks of Pfizer (PFE) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Pfizer (PFE) yield today?

The yield of Pfizer (PFE) was 0,85% in the last month, -9,02% in the last year and -15,20% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 1,71 in dividends, um Dividend Yield de 6,25%.If you wanted to buy 100 stocks of Pfizer (PFE) today, the total investment would be US$ 2.478,00, based on the current price of US$ 24,78.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 2.254,48In 5 years: US$ 2.101,34In 10 years: 2.821,70It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Pfizer Inc.

Price

US$ 24,78

variation (12m)

-9,02%

p/l

16,92

p/vp

1,75

DIVIDEND YIELD

6,25%

price PFE

BVMF

PFE

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of PFE

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

0,85%

3 months

-1,72%

1 year

-9,02%

2 years

-14,58%

5 years

-15,20%

10 years

13,87%

real profitability

profitability minus inflation.

1 month

0,85%

3 months

-2,08%

1 year

-13,01%

2 years

-22,04%

5 years

-37,34%

10 years

-31,82%

Indicators PFE

check out the fundamentals of Pfizer shares

P/E

16,92

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

2,56

Sector: -4,23 Industry: -4,23

P/BV

1,75

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

6,25%

Sector: - Industry: -

ROA

4,46%

Sector: -63,87% Industry: -63,87%

ROE

10,33%

Sector: -70,87% Industry: -70,87%

ROIC

7,58%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

15,13%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

73,17%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

24,91%

Sector: -41,04% Industry: -41,04%

P/EBITDA

8,74

Sector: -3,65 Industry: -3,65

P/EBIT

13,46

Sector: -3,64 Industry: -3,64

P/ASSET

0,75

Sector: 1,41 Industry: 1,41

BVPS

15,66

Sector: 1,84 Industry: 1,84

EPS

1,62

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,43

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

7,75%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

4,81%

Sector: - Industry: -

FAIR PRICE OF Pfizer ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 24,78

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-3,59%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

PFE indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of PFE with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History PFE

current DY: 6,25%

5-year average DY: 4,86%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	25/07/2025	02/09/2025	0,43000000
Dividends	09/05/2025	13/06/2025	0,43000000
Dividends	24/01/2025	07/03/2025	0,43000000
Dividends	08/11/2024	02/12/2024	0,42000000
Dividends	26/07/2024	03/09/2024	0,42000000
Dividends	10/05/2024	14/06/2024	0,42000000
Dividends	26/01/2024	01/03/2024	0,42000000
Dividends	10/11/2023	04/12/2023	0,41000000
Dividends	28/07/2023	05/09/2023	0,41000000
Dividends	12/05/2023	09/06/2023	0,41000000
Dividends	25/01/2023	03/03/2023	0,41000000
Dividends	04/11/2022	05/12/2022	0,40000000
Dividends	29/07/2022	06/09/2022	0,40000000
Dividends	13/05/2022	10/06/2022	0,40000000
Dividends	28/01/2022	04/03/2022	0,40000000
Dividends	05/11/2021	06/12/2021	0,39000000
Dividends	30/07/2021	07/09/2021	0,39000000
Dividends	07/05/2021	04/06/2021	0,03900000
Dividends	29/01/2021	05/03/2021	0,39000000
Dividends	06/11/2020	01/12/2020	0,38000000
Dividends	31/07/2020	01/09/2020	0,38000000
Dividends	08/05/2020	05/06/2020	0,38000000
Dividends	31/01/2020	06/03/2020	0,38000000
Dividends	08/11/2019	02/12/2019	0,36000000
Dividends	02/08/2019	03/09/2019	0,36000000
Dividends	10/05/2019	07/06/2019	0,36000000
Dividends	01/02/2019	01/03/2019	0,36000000
Dividends	09/11/2018	03/12/2018	0,34000000
Dividends	03/08/2018	04/09/2018	0,34000000
Dividends	11/05/2018	01/06/2018	0,34000000
Dividends	02/02/2018	01/03/2018	0,34000000
Dividends	10/11/2017	01/12/2017	0,32000000
Dividends	04/08/2017	01/09/2017	0,32000000
Dividends	12/05/2017	01/06/2017	0,32000000
Dividends	03/02/2017	01/03/2017	0,32000000
Dividends	11/11/2016	01/12/2016	0,30000000
Dividends	05/08/2016	01/09/2016	0,30000000
Dividends	13/05/2016	01/06/2016	0,30000000
Dividends	05/02/2016	02/03/2016	0,30000000
Dividends	06/11/2015	01/12/2015	0,28000000
Dividends	07/08/2015	02/09/2015	0,28000000
Dividends	08/05/2015	02/06/2015	0,28000000
Dividends	06/02/2015	03/03/2015	0,28000000
Dividends	07/11/2014	02/12/2014	0,26000000
Dividends	01/08/2014	03/09/2014	0,26000000
Dividends	09/05/2014	03/06/2014	0,26000000
Dividends	07/02/2014	04/03/2014	0,26000000
Dividends	08/11/2013	03/12/2013	0,24000000
Dividends	02/08/2013	04/09/2013	0,24000000
Dividends	10/05/2013	04/06/2013	0,24000000
Dividends	01/02/2013	05/03/2013	0,24000000
Dividends	09/11/2012	04/12/2012	0,22000000
Dividends	03/08/2012	05/09/2012	0,22000000
Dividends	11/05/2012	05/06/2012	0,22000000
Dividends	03/02/2012	06/03/2012	0,22000000
Dividends	11/11/2011	06/12/2011	0,20000000
Dividends	05/08/2011	06/09/2011	0,20000000
Dividends	13/05/2011	07/06/2011	0,20000000
Dividends	04/02/2011	01/03/2011	0,20000000
Dividends	08/11/2010	01/12/2010	0,18000000
Dividends	06/08/2010	01/09/2010	0,18000000
Dividends	07/05/2010	01/06/2010	0,18000000
Dividends	05/02/2010	02/03/2010	0,18000000
Dividends	06/11/2009	01/12/2009	0,16000000
Dividends	07/08/2009	02/09/2009	0,16000000
Dividends	08/05/2009	02/06/2009	0,16000000
Dividends	06/02/2009	03/03/2009	0,32000000
Dividends	07/11/2008	02/12/2008	0,32000000
Dividends	08/08/2008	03/09/2008	0,32000000
Dividends	09/05/2008	03/06/2008	0,32000000
Dividends	08/02/2008	04/03/2008	0,32000000
Dividends	09/11/2007	04/12/2007	0,29000000
Dividends	10/08/2007	05/09/2007	0,29000000
Dividends	11/05/2007	05/06/2007	0,29000000
Dividends	09/02/2007	06/03/2007	0,29000000
Dividends	10/11/2006	05/12/2006	0,24000000
Dividends	11/08/2006	05/09/2006	0,24000000
Dividends	12/05/2006	06/06/2006	0,24000000
Dividends	10/02/2006	07/03/2006	0,24000000
Dividends	11/11/2005	06/12/2005	0,19000000
Dividends	12/08/2005	06/09/2005	0,19000000
Dividends	13/05/2005	07/06/2005	0,19000000
Dividends	11/02/2005	08/03/2005	0,19000000
Dividends	12/11/2004	03/12/2004	0,17000000
Dividends	13/08/2004	03/09/2004	0,17000000
Dividends	14/05/2004	04/06/2004	0,17000000
Dividends	13/02/2004	05/03/2004	0,17000000
Dividends	14/11/2003	04/12/2003	0,15000000
Dividends	15/08/2003	04/09/2003	0,15000000
Dividends	16/05/2003	05/06/2003	0,15000000
Dividends	17/01/2003	14/02/2003	0,15000000
Dividends	15/11/2002	05/12/2002	0,13000000
Dividends	16/08/2002	05/09/2002	0,13000000
Dividends	17/05/2002	06/06/2002	0,13000000
Dividends	15/02/2002	07/03/2002	0,13000000
Dividends	16/11/2001	06/12/2001	0,11000000
Dividends	17/08/2001	06/09/2001	0,11000000
Dividends	18/05/2001	07/06/2001	0,11000000
Dividends	16/02/2001	08/03/2001	0,11000000
Dividends	17/11/2000	07/12/2000	0,09000000
Dividends	18/08/2000	07/09/2000	0,09000000
Dividends	11/05/2000	08/06/2000	0,09000000
Dividends	18/02/2000	09/03/2000	0,09000000
Dividends	12/11/1999	09/12/1999	0,08000000
Dividends	06/08/1999	09/09/1999	0,08000000
Dividends	07/05/1999	10/06/1999	0,07333333
Dividends	12/02/1999	11/03/1999	0,07333333
Dividends	06/11/1998	10/12/1998	0,06333333
Dividends	07/08/1998	10/09/1998	0,06333333
Dividends	08/05/1998	11/06/1998	0,06333333
Dividends	06/02/1998	12/03/1998	0,06333333
Dividends	07/11/1997	11/12/1997	0,05666667
Dividends	01/08/1997	11/09/1997	0,05666667
Dividends	09/05/1997	12/06/1997	0,05665000
Dividends	07/02/1997	13/03/1997	0,05665000
Dividends	08/11/1996	12/12/1996	0,05001667
Dividends	02/08/1996	12/09/1996	0,05001667
Dividends	10/05/1996	13/06/1996	0,05001667
Dividends	09/02/1996	14/03/1996	0,05001667
Dividends	10/11/1995	21/12/1995	0,04331667
Dividends	04/08/1995	21/09/1995	0,04331667
Dividends	12/05/1995	15/06/1995	0,04331667
Dividends	10/02/1995	16/03/1995	0,04331667
Dividends	11/11/1994	15/12/1994	0,03915833
Dividends	05/08/1994	15/09/1994	0,03915833
Dividends	13/05/1994	16/06/1994	0,03915833
Dividends	11/02/1994	17/03/1994	0,03915833
Dividends	12/11/1993	16/12/1993	0,03499167
Dividends	06/08/1993	16/09/1993	0,03499167
Dividends	14/05/1993	17/06/1993	0,03499167
Dividends	12/02/1993	18/03/1993	0,03499167
Dividends	20/11/1992	17/12/1992	0,03083333
Dividends	07/08/1992	17/09/1992	0,03083333
Dividends	15/05/1992	18/06/1992	0,03083333
Dividends	07/02/1992	19/03/1992	0,03083333
Dividends	15/11/1991	19/12/1991	0,02750833
Dividends	07/08/1991	19/09/1991	0,02750833
Dividends	17/05/1991	20/06/1991	0,02750833
Dividends	28/02/1991	21/03/1991	0,02750833
Dividends	16/11/1990	20/12/1990	0,02497917
Dividends	10/08/1990	20/09/1990	0,02497917
Dividends	18/05/1990	21/06/1990	0,02497917
Dividends	09/02/1990	22/03/1990	0,02497917

ABOUT THE COMPANY Pfizer

Pfizer Inc.

Average user rating I10

4.0 (706 people)

Estados Unidos

83 years

Foundation: 1942

1951

Year of debut on the stock exchange - 74 years

78.500

Employees

Additional Information

The Company Pfizer Inc. (Estados Unidos), is listed on NYSE with a market value of $ 155,60 Billions, having a net worth of $ 89,01 Billions.

With a total of 78.500 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 60,79 Billions, which generated a profit in the amount of $ 9,20 Billions.

As for its main indicators, the Company has a P/E ratio of 16,92, a P/BV ratio of 1,75 and in the last 12 months the dividend yield of PFE was at 6,25%.

The Company is traded internationally through the ticker PFE.

Market value

US$ 155,60 Billions

Net worth

US$ 89,01 Billions

US$ 89.012.000.000,00

Assets

US$ 206,10 Billions

US$ 206.095.000.000,00

Total Number of Shares

5,69 Billions

5.685.000.000

Average Daily Trading Volume

US$ 50,14 Milhões

US$ 50.136.152,00

Sector

Health Care

Industry

Biotechnology

PFE

PFE revenue and profits

PFE results

DRAG THE FRAME TO SEE MORE DATA

PFE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BMY - Bristol-Myers Squibb

US$ 43,96 --10,61% (12M)

P/L

17,97

5,41%

ROE

29,44%

P/VP

5,29

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BMY - Bristol-Myers Squibb

US$ 43,96 --10,61% (12 M)

P/L

17,97

5,41%

ROE

29,44%

P/VP

5,29

Frequently Asked Questions

What is the price of Pfizer (PFE) today?

The price of Pfizer (PFE) today is US$ 24,78, with a variation of -9.02% compared to the last year. The price of Pfizer (PFE) started the year trading around US$ 0,00 and today it is at US$ 24,78. Follow the real-time price chart, the historical price of Pfizer (PFE), and stock data from Ibovespa and international markets.

When does Pfizer (PFE) pay dividends?

Pfizer (PFE) distributed dividends in the last year,in the months of March, June and September totaling US$ 1,29. The Dividend Yield for the last 12 months is 6,25%.

Pfizer (PFE) is it worth it?

Currently, Pfizer (PFE) is priced at US$ 24,78, with a P/E of 16,92%, representing a deviation of -254,22% from its historical average P/E. In the last year, the stock showed a variation of -9.02% in its price and distributed US$ 1,29 in dividends, resulting in a Dividend Yield of 6,25%. The total shareholder return was -9,02%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Pfizer (PFE)?

Investing in stocks of Pfizer (PFE) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Pfizer (PFE) yield today?

The yield of Pfizer (PFE) was 0,85% in the last month, -9,02% in the last year and -15,20% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 1,71 in dividends, um Dividend Yield de 6,25%.

If you wanted to buy 100 stocks of Pfizer (PFE) today, the total investment would be US$ 2.478,00, based on the current price of US$ 24,78.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 2.254,48
In 5 years: US$ 2.101,34
In 10 years: 2.821,70

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

PFE

Pfizer Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of PFE

check out the fundamentals of Pfizer shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 6,25%

5-year average DY: 4,86%

type

date with

payment date

value

ABOUT THE COMPANY Pfizer

Pfizer Inc.

Estados Unidos

83 years

1951

78.500

Additional Information

PROFIT X PRICE PFE

PFE results

PFE cash flow

evolution of assets - PFE

PFE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions